Imugene, Merck To Evaluate HER-Vaxx - KEYTRUDA Combination I

KENILWORTH (NJ) (dpa-AFX) - Imugene (IMU.AX) said that it has reached a new clinical trial collaboration and supply agreement with Merck & Co Inc. (MRK) to evaluate the safety and efficacy of Imugene's

Related Keywords

, Merck Co Inc , Imugene , Merck , Valuate , Vaxx , Keytruda , Combination , Hase , Trial , Pastric , Dancer ,